197 related articles for article (PubMed ID: 21903324)
1. Targeting p73 in cancer.
Maas AM; Bretz AC; Mack E; Stiewe T
Cancer Lett; 2013 May; 332(2):229-36. PubMed ID: 21903324
[TBL] [Abstract][Full Text] [Related]
2. The p73 tumor suppressor is targeted by Pirh2 RING finger E3 ubiquitin ligase for the proteasome-dependent degradation.
Jung YS; Qian Y; Chen X
J Biol Chem; 2011 Oct; 286(41):35388-35395. PubMed ID: 21852228
[TBL] [Abstract][Full Text] [Related]
3. TP73, an under-appreciated player in non-Hodgkin lymphoma pathogenesis and management.
Hassan HM; Dave BJ; Singh RK
Curr Mol Med; 2014 May; 14(4):432-9. PubMed ID: 24730526
[TBL] [Abstract][Full Text] [Related]
4. Role of p73 in malignancy: tumor suppressor or oncogene?
Stiewe T; Pützer BM
Cell Death Differ; 2002 Mar; 9(3):237-45. PubMed ID: 11859406
[TBL] [Abstract][Full Text] [Related]
5. CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer.
Lu H; Yan C; Quan XX; Yang X; Zhang J; Bian Y; Chen Z; Van Waes C
Neoplasia; 2014 Oct; 16(10):789-800. PubMed ID: 25379016
[TBL] [Abstract][Full Text] [Related]
6. Regulation of p73 activity by post-translational modifications.
Conforti F; Sayan AE; Sreekumar R; Sayan BS
Cell Death Dis; 2012 Mar; 3(3):e285. PubMed ID: 22419114
[TBL] [Abstract][Full Text] [Related]
7. A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells.
Yu J; Baron V; Mercola D; Mustelin T; Adamson ED
Cell Death Differ; 2007 Mar; 14(3):436-46. PubMed ID: 16990849
[TBL] [Abstract][Full Text] [Related]
8. Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line.
Goldschneider D; Blanc E; Raguénez G; Barrois M; Legrand A; Le Roux G; Haddada H; Bénard J; Douc-Rasy S
J Cell Sci; 2004 Jan; 117(Pt 2):293-301. PubMed ID: 14676279
[TBL] [Abstract][Full Text] [Related]
9. In good times and bad: p73 in cancer.
Oswald C; Stiewe T
Cell Cycle; 2008 Jun; 7(12):1726-31. PubMed ID: 18583938
[TBL] [Abstract][Full Text] [Related]
10. p73.
Davis PK; Dowdy SF
Int J Biochem Cell Biol; 2001 Oct; 33(10):935-9. PubMed ID: 11470228
[TBL] [Abstract][Full Text] [Related]
11. The p53 family protein p73 provides new insights into cancer chemosensitivity and targeting.
Lunghi P; Costanzo A; Mazzera L; Rizzoli V; Levrero M; Bonati A
Clin Cancer Res; 2009 Nov; 15(21):6495-502. PubMed ID: 19861456
[TBL] [Abstract][Full Text] [Related]
12. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.
Zaika AI; Slade N; Erster SH; Sansome C; Joseph TW; Pearl M; Chalas E; Moll UM
J Exp Med; 2002 Sep; 196(6):765-80. PubMed ID: 12235210
[TBL] [Abstract][Full Text] [Related]
13. p73 or p53 directly regulates human p53 transcription to maintain cell cycle checkpoints.
Wang S; El-Deiry WS
Cancer Res; 2006 Jul; 66(14):6982-9. PubMed ID: 16849542
[TBL] [Abstract][Full Text] [Related]
14. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
Murray-Zmijewski F; Lane DP; Bourdon JC
Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
[TBL] [Abstract][Full Text] [Related]
15. Loss of Expression of Reprimo, a p53-induced Cell Cycle Arrest Gene, Correlates with Invasive Stage of Tumor Progression and p73 Expression in Gastric Cancer.
Saavedra K; Valbuena J; Olivares W; Marchant MJ; Rodríguez A; Torres-Estay V; Carrasco-Avino G; Guzmán L; Aguayo F; Roa JC; Corvalán AH
PLoS One; 2015; 10(5):e0125834. PubMed ID: 25954972
[TBL] [Abstract][Full Text] [Related]
16. p73 as a pharmaceutical target for cancer therapy.
Bisso A; Collavin L; Del Sal G
Curr Pharm Des; 2011; 17(6):578-90. PubMed ID: 21391908
[TBL] [Abstract][Full Text] [Related]
17. p63 and p73: roles in development and tumor formation.
Moll UM; Slade N
Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
[TBL] [Abstract][Full Text] [Related]
18. p73 induces apoptosis by different mechanisms.
Ramadan S; Terrinoni A; Catani MV; Sayan AE; Knight RA; Mueller M; Krammer PH; Melino G; Candi E
Biochem Biophys Res Commun; 2005 Jun; 331(3):713-7. PubMed ID: 15865927
[TBL] [Abstract][Full Text] [Related]
19. BRCA1-associated epigenetic regulation of p73 mediates an effector pathway for chemosensitivity in ovarian carcinoma.
Ibrahim N; He L; Leong CO; Xing D; Karlan BY; Swisher EM; Rueda BR; Orsulic S; Ellisen LW
Cancer Res; 2010 Sep; 70(18):7155-65. PubMed ID: 20807817
[TBL] [Abstract][Full Text] [Related]
20. Relative expression of TAp73 and ΔNp73 isoforms.
Conforti F; Yang AL; Agostini M; Rufini A; Tucci P; Nicklison-Chirou MV; Grespi F; Velletri T; Knight RA; Melino G; Sayan BS
Aging (Albany NY); 2012 Mar; 4(3):202-5. PubMed ID: 22388545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
